Small Joints & Extremities Reconstruction (Arthroplasty) Devices

624 views

Published on

The small joint and extremities reconstruction market is growing faster than the hip and knee replacement market. New advanced technologies will help this specialty market grow at a CAGR of about 9 percent over the next few years. Compared to replacement of large joints, small joint reconstruction is a far less common procedure, although the devices have been around for the last few decades. A steady stream of innovations, many developed by the surgeons themselves, underscores the urgent need to meet growing patient demand.
The US and Europe account for the predominant share of the small joints replacement market. Emerging healthcare markets are currently focused on large joint replacements, although small joint procedures will soon catch up.


Key trends and characteristics in this market include:

Joint diseases will continue being the leading cause of disability in older people. Growth of this patient base is accelerating as populations around the world age, and rates of chronic inflammatory diseases, osteoarthritis and obesity soar.
Despite the high complication rate, clinical studies from all over the world show that arthroplasty can be used to successfully treat degenerative diseases and repetitive motion injuries caused by sports and occupational tasks.
Patient demands are also changing with increasing life expectancy. People with end-stage arthritis are looking for treatment alternatives to arthrodesis that restore mobility and offer a greater quality of life.
Shoulder replacement or arthroplasty devices are the most common type of small joint replacements, accounting for almost three quarters of the $917million market in 2011.
Elbow and ankle replacements offer high growth potential due to high rates of injury. There are only a handful of ankle replacement devices leaving a wide open field for new entrants.
Extremities reconstruction, namely digits, comprises the smallest segment of this market, due in large part to procedural complexity.
The severe shortage of trained surgeons is a major restraint needing to be addressed.
More successful technologies are critical in clearing regulatory hurdles, improving reimbursement, and patient acceptance.
The market is dominated by well-established joint reconstruction specialists such as DePuy, Tornier, Zimmer and Biomet, closely followed by other orthopedic giants like Stryker, Smith and Nephew and Wright Medical. These companies compete fiercely for high-end products with highly reputed niche players such as Integra Life Sciences and Small Bone Innovations.

Published in: Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
624
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
5
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Small Joints & Extremities Reconstruction (Arthroplasty) Devices

  1. 1. Small Joints and Extremities Reconstruction(Arthroplasty) Devices Markets Worldwide Report Highlights 2012
  2. 2. Report BenefitsThis report can help in:• Assessing the world market for small joints and extremities reconstruction (arthroplasty), growth segments and opportunities.• Understanding market drivers and restraints, market segmentation, market shares and competitive segmentation.• Strategic planning and competitive strategy.• Identifying opportunities for partnerships and alliances. © 2012 Marketstrat, Inc., All Rights Reserved 2
  3. 3. Key Takeaways• The world market for small joint and extremity reconstruction (arthroplasty) is estimated around approach close to $1 billion by the end of 2012. This market will grow at a CAGR of about 9 percent over the forecast period.• Key product segments: The shoulder replacement is the largest product segment; the US is the largest geographic segment.• Key Drivers: Prevalence of disabling joint diseases in aging populations and young people engaging in sports and fitness; new technology, patient awareness and demand for treatment options that offer an alternative to arthrodesis are important drivers. Skyrocketing rates of co-morbidities such as diabetes and obesity are adding to the risk of developing degenerative joint diseases.• Key Restraints: High rate of complications, failure and revision have plagued the small joint replacement market. Other restraints include a severe shortage of trained surgeons, reimbursement restrictions and regulatory hurdles.• Leaders: Well-established orthopedic specialists such as DePuy, Biomet, Tornier and Zimmer. Mid-tier players are Stryker and Smith & Nephew and Wright Medical. All these providers also offer the top brands of hip and knee replacements. Highly reputed niche players in small joint replacements are Integra Life Sciences and Small Bone Innovations. © 2012 Marketstrat, Inc., All Rights Reserved 3
  4. 4. Sample Data TableWorld - Elbow Reconstruction Devices Market - Revenue Forecasts by Country/Region - 2010-2018 ($ Million) 2010 2011 2012 2013 2014 2015 2016 2017 2018 CAGRUSA ($mill) $38.6 $42.5 $46.9 $51.7 $57.1 $63.2 $70.0 $77.6 $86.2 GROWTH (%) 10.2% 10.2% 10.3% 10.5% 10.6% 10.8% 10.9% 11.1% 10.6%EUROPE ($mill) $16.9 $18.4 $20.0 $21.8 $23.8 $26.0 $28.4 $31.0 $33.9 GROWTH (%) 8.8% 8.9% 8.9% 9.1% 9.2% 9.2% 9.3% 9.3% 9.1%JAPAN ($mill) $7.7 $8.2 $8.7 $9.4 $10.1 $10.8 $11.7 $12.6 $13.6 GROWTH (%) 6.9% 6.9% 7.2% 7.4% 7.6% 7.7% 7.9% 8.1% 7.5%ROW ($mill) $21.7 $22.8 $23.9 $25.1 $26.3 $27.7 $29.1 $30.7 $32.3 GROWTH (%) 4.9% 4.9% 5.0% 5.1% 5.1% 5.2% 5.3% 5.3% 5.1%TOTAL ($ Million) $84.9 $91.9 $99.5 $107.9 $117.3 $127.7 $139.1 $151.8 $166.0GROWTH (%) 8.2% 8.3% 8.5% 8.7% 8.8% 9.0% 8.6%Notes:1. Includes implants for elbow reconstruction2. ROW includes all countries/regions other than USA, Europe and Japan3. Data are at the manufacturer levelSource: Marketstrat™ © 2012 Marketstrat, Inc., All Rights Reserved 4
  5. 5. Sample Data TableJapan - ANKLE RECONSTRCUTION MARKET - UNIT SALES FORECASTS (2010 to 2018) Year UNIT SALES Growth (%) 2010 1,038 2011 1,104 6.3% 2012 1,173 6.3% 2013 1,247 6.3% 2014 1,326 6.4% 2015 1,411 6.4% 2016 1,503 6.5% 2017 1,601 6.6% 2018 1,708 6.7% CAGR 6.4%Notes:1. Includes implants for ankle reconstruction2. Data are at the manufacturer levelSource: Marketstrat® © 2011 Marketstrat, Inc., All Rights June 12 5 Reserved
  6. 6. Sample Data Chart USA -ANKLE RECONSTRUCTION MARKET - REVENUE FORECASTS ( $ Million, 2010 to 2018) $60.0 8.7% 8.6% $50.0 8.5% illio )R en es ($M n $40.0 8.4% ro th 8.3% %G w $30.0 8.2% 8.1% ev u $20.0 8.0% $10.0 7.9% 7.8% $0.0 7.7% 2010 2011 2012 2013 2014 2015 2016 2017 2018 REVENUE FORECASTS ($ Million) Source: Marketstrat® © 2012 Marketstrat, Inc., All Rights Reserved 6
  7. 7. Report StatsCategory DetailRegions Covered US, Europe, Japan, ROWProduct Segments • Digits (Fingers, Toes) • Wrist • Elbow • Shoulder • AnkleCompany Profiles 21 CompaniesMarket Estimates/ Forecasts Revenues ($) and Unit Sales for 2010-2018Report Code 332-12Price $2995 (single-user license); $5990 (corporate license)No. of Pages 192 pages; 63 data tables; 56 chartsPublication Date July 2012 © 2012 Marketstrat, Inc., All Rights Reserved 7
  8. 8. About UsMarketstrat specializes in Medical Market Research. We assist companies with market, technology, and best practice strategies & intelligence, through a unique combination of published reports, solutions, and services.Our strengths include: a deep understanding of the medical devices value chain, state-of-the-art data collection tools, and a robust research methodology. 4695 Chabot Drive, Suite 200 Pleasanton, CA 94588, USA. Email : info@marketstrat.com Phone: 925-263-4455 Fax: 925-263-4456 www.marketstrat.com © 2012 Marketstrat, Inc., All Rights Reserved 8
  9. 9. © 2012 Marketstrat, Inc., All Rights Reserved 9

×